og体育
join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
og体育:Development History
og体育:Quality Management
og体育:Contact Us
Legal Statement
og体育:Adverse Reaction Report
Science and Technology
R&D platform
og体育:R&D pipeline
Therapeutic Field
og体育:International Business
APIs
og体育:Finished Products
og体育:Medical device
Download product list
Contact
og体育:News Center
News & Trends
og体育:Public information
News & Trends
022022-08
The updated progress of clinical t♒rial for SAL0114
272022-07
SAL007 for the treat𓄧ment of ch🌸ronic heart failure approved by NMPA for clinical trial
282022-06
Upda🥂ted progress of S086 tablets in Phase 3 clinical trial for the treatment of chronic heart failure
282022-06
Updatedಞ progress of Fotagliptin benzoate tablets in Phase 3 clinical ꩲtrial for the treatment of diabetes
212022-06
Salubris’ LAMax LAAC® left atrial appenไdage closure system rec♌eives NMPA approval
272022-05
Updated progress of Allisartan Isoproxil and Indapamide sustained-rele𒁏ase tablets in Phase 3 trial for ♑the treatment of essential hypertension
目前在第
5
页,
共有
9
页,
共有
50
条记录
第一页
上一页
3
4
5
6
7
下一页
最后一页
跳转到
页
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7fDzSfyJvbjbD",ck:"K9y7fDzSfyJvbjbD"});
谈球吧体育(中国) - 官网app下载
OG体育(中国) - 官方网站
OG体育·(中国)平台
og体育(中国)- app下载